Interleukin-1β assembles a proangiogenic signaling module consisting of caveolin-1, Tumor necrosis factor receptor-associated factor 6, p38-mitogen-activated protein kinase (MAPK), and mapk-activated protein kinase 2 in endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 5, 2012, Pages 1280-1288

  Jagielska, Joanna ^a   Kapopara, Piyushkumar R ^a   Salguero, Gustavo ^a   Scherr, Michaela ^a   Schütt, Harald ^a   Grote, Karsten ^a   Schieffer, Bernhard ^a   Bavendiek, Udo ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Angiogenesis; Endothelium; Signal transduction; Vascular biology

Indexed keywords

CAVEOLIN 1; CYCLODEXTRIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CELL MOTION; COMPARATIVE STUDY; DISEASE MODEL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; CAVEOLIN 1; CELL MOVEMENT; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HUMANS; INTERLEUKIN-1; MAP KINASE KINASE 2; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 84860225411     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.243477     Document Type: Article

References (37)

1. Dinarello CA. Blocking IL-1 in systemic inflammation. J Exp Med. 2005;201:1355-1359. (Pubitemid 40664079)
2. Voronov E, Carmi Y, Apte RN. Role of IL-1-mediated inflammation in tumor angiogenesis. Adv Exp Med Biol. 2007;601:265-270.
3. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y, Dinarello CA, Apte RN. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA. 2003;100:2645-2650. (Pubitemid 36297552)
4. Bar D, Apte RN, Voronov E, Dinarello CA, Cohen S. A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development. FASEB J. 2004;18:161-163.
5. Naldini A, Leali D, Pucci A, Morena E, Carraro F, Nico B, Ribatti D, Presta M. Cutting edge: IL-1bmediates the proangiogenic activity of osteopontin-activated human monocytes. J Immunol. 2006;177:4267-4270. (Pubitemid 44469753)
6. Carmi Y, Voronov E, Dotan S, Lahat N, Rahat MA, Fogel M, Huszar M, White MR, Dinarello CA, Apte RN. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis. J Immunol. 2009;183:4705-4714.
7. Auron PE. The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine Growth Factor Rev. 1998;9:221-237. (Pubitemid 29019708)
8. Janssens S, Beyaert R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol Cell. 2003;11:293-302. (Pubitemid 36293825)
9. Pollet I, Opina CJ, Zimmerman C, Leong KG, Wong F, Karsan A. Bacterial lipopolysaccharide directly induces angiogenesis through TRAF6-mediated activation of NF-kB and c-Jun N-terminal kinase. Blood. 2003;102:1740-1742. (Pubitemid 37022568)
10. Gaestel M. MAPKAP kinases-MKs-two's company, three's a crowd. Nat Rev Mol Cell Biol. 2006;7:120-130. (Pubitemid 43278295)
11. Rousseau S, Dolado I, Beardmore V, Shpiro N, Marquez R, Nebreda AR, Arthur JS, Case LM, Tessier-Lavigne M, Gaestel M, Cuenda A, Cohen P. CXCL12 and C5a trigger cell migration via a PAK1/2-p38a MAPK-MAPKAP-K2-HSP27 pathway. Cell Signal. 2006;18:1897-1905. (Pubitemid 44485980)
12. Feng X, Gaeta ML, Madge LA, Yang JH, Bradley JR, Pober JS. Caveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptors. J Biol Chem. 2001;276:8341-8349.
13. Arron JR, Pewzner-Jung Y, Walsh MC, Kobayashi T, Choi Y. Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling. J Exp Med. 2002;196:923-934.
14. Frank PG, Woodman SE, Park DS, Lisanti MP. Caveolin, caveolae, and endothelial cell function. Arterioscler Thromb Vasc Biol. 2003;23:1161-1168. (Pubitemid 36871269)
15. Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev. 2004;84:1341-1379. (Pubitemid 39287953)
16. Chidlow JH Jr, Sessa WC. Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. Cardiovasc Res. 2010;86:219-225.
17. Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk HD, Gaestel M. MAPKAP kinase 2 is essential for LPS-induced TNF-a biosynthesis. Nat Cell Biol. 1999;1:94-97. (Pubitemid 129501950)
18. Kostenko S, Moens U. Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell Mol Life Sci. 2009;66:3289-3307.
19. Ilangumaran S, Hoessli DC. Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane. Biochem J. 1998;335(Pt 2):433-440. (Pubitemid 28491081)
20. Darblade B, Caillaud D, Poirot M, Fouque M, Thiers JC, Rami J, Bayard F, Arnal JF. Alteration of plasmalemmal caveolae mimics endothelial dysfunction observed in atheromatous rabbit aorta. Cardiovasc Res. 2001;50:566-576. (Pubitemid 32480250)
21. Naito A, Azuma S, Tanaka S, Miyazaki T, Takaki S, Takatsu K, Nakao K, Nakamura K, Katsuki M, Yamamoto T, Inoue J. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells. 1999;4:353-362. (Pubitemid 29359450)
22. Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, Ho A, Morony S, Capparelli C, Van G, Kaufman S, van der Heiden A, Itie A, Wakeham A, Khoo W, Sasaki T, Cao Z, Penninger JM, Paige CJ, Lacey DL, Dunstan CR, Boyle WJ, Goeddel DV, Mak TW. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 1999;13:1015-1024. (Pubitemid 29200984)
23. Kerbel RS. Tumor angiogenesis. N Engl J Med. 2008;358:2039-2049. (Pubitemid 351656458)
24. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, Lo KM, Gillies S, Javaherian K, Folkman J. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA. 2003;100:4736-4741. (Pubitemid 36457799)
25. Mountain DJ, Singh M, Singh K. Interleukin-1b-mediated inhibition of the processes of angiogenesis in cardiac microvascular endothelial cells. Life Sci. 2008;82:1224-1230.
26. Hostager BS, Catlett IM, Bishop GA. Recruitment of CD40 and tumornecrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling. J Biol Chem. 2000;275:15392-15398. (Pubitemid 30337269)
27. Li H, Nord EP. Functional caveolae are a prerequisite for CD40 signaling in human renal proximal tubule cells. Am J Physiol Renal Physiol. 2004;286:F711-F719. (Pubitemid 38365090)
28. Ha H, Kwak HB, Le SW, Kim HH, Lee ZH. Lipid rafts are important for the association of RANK and TRAF6. Exp Mol Med. 2003;35:279-284. (Pubitemid 37152642)
29. Ha H, Kwak HB, Lee SK, Na DS, Rudd CE, Lee ZH, Kim HH. Membrane rafts play a crucial role in receptor activator of nuclear factor kB signaling and osteoclast function. J Biol Chem. 2003;278:18573-18580. (Pubitemid 36799484)
30. Legler DF, Micheau O, Doucey MA, Tschopp J, Bron C. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFa-mediated NF-kB activation. Immunity. 2003;18:655-664. (Pubitemid 36588582)
31. D'Alessio A, Al-Lamki RS, Bradley JR, Pober JS. Caveolae participate in tumor necrosis factor receptor 1 signaling and internalization in a human endothelial cell line. Am J Pathol. 2005;166:1273-1282. (Pubitemid 40524450)
32. Soong G, Reddy B, Sokol S, Adamo R, Prince A. TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J Clin Invest. 2004;113:1482-1489. (Pubitemid 39071704)
33. Liu J, Wang XB, Park DS, Lisanti MP. Caveolin-1 expression enhances endothelial capillary tubule formation. J Biol Chem. 2002;277:10661-10668. (Pubitemid 34968193)
34. Woodman SE, Ashton AW, Schubert W, Lee H, Williams TM, Medina FA, Wyckoff JB, Combs TP, Lisanti MP. Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli. Am J Pathol. 2003;162:2059-2068. (Pubitemid 36613061)
35. D'Alessio A, Kluger MS, Li JH, Al-Lamki R, Bradley JR, Pober JS. Targeting of tumor necrosis factor receptor 1 to low density plasma membrane domains in human endothelial cells. J Biol Chem. 2010;285:23868-23879.
36. Wang L, Lim EJ, Toborek M, Hennig B. The role of fatty acids and caveolin-1 in tumor necrosis factor a-induced endothelial cell activation. Metabolism. 2008;57:1328-1339.
37. O'Neill L. The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence. Biochem Soc Trans. 2000;28:557-563.